"EnGeneIC is a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform that enables current cancer treatments to be more potent and far less toxic, while also stimulating a potent anti-tumor immune response."
Doesn't sound "paradigm shifting" to me.... just another delivery method for the same old toxic cancer drugs....
Happy to be enlightened????
At any rate I have emmence confidence in our board and science.
The only real loser here will be cancer, and winners the cancer sufferers.
"EnGeneIC is a clinical stage biopharmaceutical company focused...
-
- There are more pages in this discussion • 24,897 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2203877 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 244428 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |